Free Trial

Scissortail Wealth Management LLC Raises Stock Position in CME Group Inc. (NASDAQ:CME)

CME Group logo with Finance background

Scissortail Wealth Management LLC grew its holdings in CME Group Inc. (NASDAQ:CME - Free Report) by 5,394.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 21,210 shares of the financial services provider's stock after acquiring an additional 20,824 shares during the period. CME Group accounts for 1.3% of Scissortail Wealth Management LLC's portfolio, making the stock its 26th largest holding. Scissortail Wealth Management LLC's holdings in CME Group were worth $4,926,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Norges Bank bought a new stake in shares of CME Group during the 4th quarter valued at $1,107,389,000. Price T Rowe Associates Inc. MD boosted its stake in shares of CME Group by 89.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 8,280,785 shares of the financial services provider's stock valued at $1,923,047,000 after purchasing an additional 3,921,278 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in CME Group in the fourth quarter worth about $871,063,000. Capital Wealth Planning LLC raised its holdings in shares of CME Group by 69.2% during the fourth quarter. Capital Wealth Planning LLC now owns 2,435,823 shares of the financial services provider's stock worth $565,671,000 after purchasing an additional 996,498 shares during the last quarter. Finally, Egerton Capital UK LLP purchased a new position in CME Group in the fourth quarter valued at $223,967,000. 87.75% of the stock is currently owned by institutional investors.

Insider Transactions at CME Group

In other news, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction that occurred on Thursday, February 27th. The shares were sold at an average price of $250.47, for a total value of $997,872.48. Following the sale, the insider now directly owns 27,046 shares in the company, valued at $6,774,211.62. This represents a 12.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Suzanne Sprague sold 1,500 shares of the stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $256.83, for a total value of $385,245.00. Following the sale, the chief operating officer now owns 8,036 shares in the company, valued at approximately $2,063,885.88. This trade represents a 15.73% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 27,494 shares of company stock worth $7,281,618 over the last ninety days. 0.30% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the stock. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 target price for the company in a research note on Monday, March 10th. Erste Group Bank raised shares of CME Group to a "strong-buy" rating in a research note on Monday, March 17th. JPMorgan Chase & Co. dropped their price objective on shares of CME Group from $223.00 to $211.00 and set an "underweight" rating for the company in a research note on Thursday, April 24th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $265.00 to $273.00 and gave the company a "market perform" rating in a research note on Thursday, April 24th. Finally, Barclays increased their price target on shares of CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $256.80.

View Our Latest Stock Report on CME

CME Group Stock Down 0.0%

Shares of CME Group stock traded down $0.07 during trading on Tuesday, hitting $277.87. 1,389,173 shares of the stock were exchanged, compared to its average volume of 2,179,996. The stock has a market cap of $100.13 billion, a price-to-earnings ratio of 28.74, a price-to-earnings-growth ratio of 6.76 and a beta of 0.45. The firm's 50-day moving average price is $266.29 and its 200 day moving average price is $247.71. CME Group Inc. has a 12-month low of $190.70 and a 12-month high of $286.48. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.01 and a quick ratio of 1.02.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 EPS for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. The company had revenue of $1.64 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 57.52% and a return on equity of 13.62%. CME Group's quarterly revenue was up 10.4% on a year-over-year basis. During the same period in the previous year, the business posted $2.50 earnings per share. As a group, analysts forecast that CME Group Inc. will post 10.49 earnings per share for the current fiscal year.

CME Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be paid a $1.25 dividend. The ex-dividend date is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a yield of 1.80%. CME Group's dividend payout ratio is presently 50.30%.

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Further Reading

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Should You Invest $1,000 in CME Group Right Now?

Before you consider CME Group, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.

While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines